PharmaShots

MAY 19, 2023

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

Medical Schools 40

Medical Schools FDA Immunization Vaccines 40

PharmaShots

MAY 12, 2023

Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD Date: May 12, 2023 | Tags: Sanofi, Nirsevimab, RSV-Related LRTD, Clinical Trial, P-IIIb, HARMONIE Trial G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023 (..)

FDA 40

FDA Chemotherapy Immunization Hospitals 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

PharmaShots

MARCH 24, 2023

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 40

FDA Immunization 40

STAT

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains.

72

72

PharmaShots

FEBRUARY 17, 2023

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy Date: Feb 17, 2023 | Tags: Iveric Bio, Avacincaptad Pegol, Geographic Atrophy, Regulatory, US, FDA, NDA, Priority Review ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of (..)

FDA 40

FDA Vaccines 40

PharmaShots

MAY 26, 2023

Takeda and HUTCHMED's Fruquintinib Receives Priority Review from the US FDA to Treat Metastatic Colorectal Cancer Date: May 26, 2023 | Tags: Takeda, HUTCHMED, Fruquintinib, Metastatic Colorectal Cancer, Regulatory, Priority Review, US, FDA Gilead Receives EMA’s CHMP Positive Opinion to Extend the Use of Veklury (remdesivir) for COVID-19 Date: (..)

FDA 40

FDA 40

European Pharmaceutical Review

DECEMBER 9, 2022

The research projected a compound annual growth rate (CAGR) of 16.8 The research noted that the oligonucleotide synthesis market in the Asia-Pacific region is expected to develop at the quickest rate during the forecast period. Tag Copenhagen A/S (Denmark). percent from $7.7 billion in 2022. Synthesised oligonucleotides.

Compounding 87

Compounding 87

pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space.

Hospitals 121

Hospitals 121

Pharmaceutical Technology

DECEMBER 5, 2022

In 2022, a surge in the pipeline has led to cannabinoid receptors becoming the most popular target in preclinical development. Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total.

Controlled Substances 98

Controlled Substances Compounding Immunization 98

Pharmaceutical Technology

JUNE 29, 2022

This year has already been eventful when it comes to the development of therapies for rare diseases. Most, if not all, of these therapies used the FDA’s Orphan Drug Designation to aid their development plans. Additionally, pricing and access for rare disease therapies continue to be scrutinized closely.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

European Pharmaceutical Review

MARCH 1, 2023

In a recent study, Massachusetts Institute of Technology (MIT) researchers developed a new purification method to cut the costs of manufacturing protein drugs. The researchers demonstrated their method with lysozyme, an enzyme whose crystallisation properties have been well studied, and insulin.

Vaccines 94

Vaccines 94

Pharmaceutical Technology

MAY 1, 2023

Under the deal terms, Shunxi will have licence to develop, manufacture, and commercialise CTH-004 to treat several solid tumours including ovarian cancer in Greater China, including Hong Kong, Taiwan, Mainland China, and Macao. Cartherics will retain all the development and commercialisation rights for the therapy outside Greater China.

52

52

pharmaphorum

JANUARY 18, 2022

Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.

Immunization 52

Immunization 52

pharmaphorum

JULY 23, 2019

Focus New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up. The expert panel will consider exclusive research carried out by Tag and pharmaphorum across the US, Europe and Asia-Pacific among senior decision-makers in pharma and FMCG marketing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Side effects and cost implications.

Immunization 52

Immunization Hospitals Vaccines 52

pharmaphorum

DECEMBER 23, 2021

Researchers have hypothesised that inhibiting EGFR and HER3 in tandem could lead to greater efficiency and also overcome resistance to currently available EGFR-directed drugs. The post FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag appeared first on. Daiichi Sankyo and AZ are close collaborators in the ADC arena.

FDA 71

FDA Chemotherapy 71

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Hospitals 40

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Go-to-market strategies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Engagement channels.

Communication 97

Communication Insurance Packaging Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 22, 2023

Developed by Sanofi and Regeneron, Praluent was approved by the FDA in July 2015. Both drugs come with a high price tag. In its past statements shared with other outlets, Amgen stated that patents need to give researchers wide protection to incentivise new inventions. Amgen’s Repatha was greenlit a month later.

FDA 104

FDA 104

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 52

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. As covered in a previous article , the importance of R&D to develop treatments for rare diseases is high. The price is right.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Flawed funding model.

Insurance 52

Insurance Vaccines 52

pharmaphorum

JANUARY 5, 2021

Meanwhile, drugs targeting TIM-3, LAG3, VISTA and STING also coming through development. TIGIT is very much among the front runners however, and Roche is being closely pursued by other drug developers including Merck & Co with MK-7684 and Gilead/Arcus, which are also in mid-stage testing, as well as iTeos Therapeutics and Mereo BioPharma.

Chemotherapy 52

Chemotherapy Immunization FDA Labelling 52

The Checkup by Singlecare

NOVEMBER 2, 2023

GLP-1 drugs are effective: There is a substantial body of scientific research supporting the effectiveness of these medications for several weight-related health concerns. GLP-1 drugs were initially developed for controlling blood sugar (glucose) levels in people with Type 2 diabetes. What are the benefits of GLP-1 agonists? ​​GLP-1

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

pharmaphorum

DECEMBER 2, 2020

It was a success, and set the pattern for the company’s future development. Also, when supply of tartaric acid was disrupted due to the civil war and increased tariffs, Pfizer developed its production to become the leading supplier of chemicals in the US. Pfizer’s Tokyo building.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

Viseven

JUNE 23, 2022

The faster digitalization goes worldwide, the more pharma companies find out about new tools and approaches for digital self-promotion. Digitalization brought new challenges to any industry related to online activities and social influence. Pharma and the specialties of pharma’s marketing appeared to be under influence as well.

Communication 52

Communication 52

pharmaphorum

JANUARY 31, 2023

With the recent rapid rollout of Covid-19 vaccines, many people have raised questions about whether adequate research was conducted on these vaccines before approval. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 52

PharmaShots

MARCH 9, 2023

Her notable achievements can be attributed to the fact that she has been acclaimed with the Kenneth Rainin Foundation Synergy Award, Robert Wood Johnson Harold Amos Medical Faculty Development Award, Immunology Faculty Mentor of the Year, and Gastroenterology & Hepatology Teaching Award. Present company and time period: Pfizer (2 yrs.)

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

The Social Pharmacist

AUGUST 2, 2022

The constantly changing algorithms and the evolving industry significantly impact how Google and other search engines generate organic traffic for a website. SEO-friendly pharmacy businesses or websites benefit from higher visitor traffic, improved brand awareness, and increased customer conversion rates. Organic Search Listing.

52

52

pharmaphorum

NOVEMBER 16, 2022

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations. However, alongside this progress, Ben Hargreaves finds that there is also a conundrum over how to price these therapies.

131

131

pharmaphorum

NOVEMBER 28, 2022

The Linux Foundation AI & Data Foundation will house the software, which will now be available for any researcher to use for similar collaborative-data AI projects. “Researchers can now leverage privacy-preserving and secure federated learning software to drive cutting-edge collaborative medical research. .

Hospitals 71

Hospitals 71

Pharma Marketing Network

OCTOBER 4, 2020

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. I’m your host Don Langsdorf our guest today is Vlad Mkrtumyan. He’s a serial entrepreneur, a search engine marketing evangelist and a passionate networker. Vlad (LI): Great that you want to kick it off.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging 52

European Pharmaceutical Review

JULY 11, 2022

The novel coronavirus vaccine has been developed at Caltech and The University of Oxfor d. Funding of up to $30 million will support vaccine design, its development through Phase I trials and regulatory activities. . How the novel coronavirus vaccine works. 8” nanoparticles. . The mosaic?8

Vaccines 93

Vaccines Immunization 93

Roots Analysis

SEPTEMBER 13, 2023

These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody.

Labelling 40

Labelling 40

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. However, New Science is more expensive to develop. billion and $6.7

Vaccines 90

Vaccines 90